Skip to content
About
Close About
Open About
Mission
Mission & Values
Mission
Mission & Values
Solid Team
Management
Board of Directors
Founders
Solid Team
Management
Board of Directors
Founders
Working at Solid
Benefits
Open Positions
Working at Solid
Benefits
Open Positions
Our Science
Close Our Science
Open Our Science
Pipeline & Programs
Pipeline
Clinical Trials
Scientific Publications & Presentations
Pipeline & Programs
Pipeline
Clinical Trials
Scientific Publications & Presentations
Infrastructure
Manufacturing
Infrastructure
Manufacturing
Patients & Families
Close Patients & Families
Open Patients & Families
Patient & Family Information
Our Commitment
Clinical Trials
Expanded Access Policy
Patient & Family Information
Our Commitment
Clinical Trials
Expanded Access Policy
Duchenne Muscular Dystrophy
Duchenne Resources
Duchenne Muscular Dystrophy
Duchenne Resources
Friedreich’s Ataxia
Friedreich’s Ataxia Resources
Friedreich’s Ataxia
Friedreich’s Ataxia Resources
CPVT
CPVT Resources
CPVT
CPVT Resources
Partner With Us
Investors & Media
Close Investors & Media
Open Investors & Media
Overview & News
Overview
Press Releases
Presentations
Events
Governance & Financials
Governance Documents
Committee Charters
Committee Composition
SEC Filings
Stock Information
Stock Quote Chart
Historical Price Lookup
Analyst Coverage
Investor Resources
Investor FAQs
Contact Solid Biosciences
Email Alerts
Solid Team
Board of Directors
Following is the jquery code that sets the body class to the page without a photo hero
Ian F. Smith
Chairman of the Board
Bo Cumbo
President and CEO
Martin Freed, M.D., F.A.C.P.
Board Member
Ilan Ganot
Co-Founder and Strategic Advisor to the CEO
Clare Kahn, Ph.D.
Board Member
Georgia Keresty, Ph.D., M.PH.
Board Member
Sukumar Nagendran, M.D.
President, Head of Research & Development, Taysha Gene Therapies
Adam Stone
Chief Investment Officer of Perceptive Advisors
Lynne Sullivan
Chief Financial Officer at Unity Biotechnology
